Skip to content

461030.KQ

IMBdx

KOE · Healthcare · Biotechnology · KR

KRW 2,960.00
+0.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue5.6B5.3B3.4B4.0B2.6B
Cost of Revenue4.3B4.3B2.5B2.6B2.3B
Gross Profit1.3B1.0B888.1M1.4B372.2M
Operating Expenses
R&D Expense4.4B5.1B7.0B5.8B5.2B
SG&A Expense4.2B1.3B1.6B1.5B3.4B
General & Admin Expense2.8B460.5M224.0M144.9M190.8M
Selling & Marketing Expense286.9M816.4M1.4B1.4B1.2B
Other Expenses1.0B3.3B2.8B1.9B52.0M
Total Operating Expenses9.6B9.7B11.5B9.2B8.7B
Cost and Expenses14.2B14.0B14.0B11.8B11.3B
Operating Income (EBIT)(8.6B)(8.7B)(10.6B)(7.8B)(8.7B)
Non-Operating
Interest Income401.9M646.0M835.4M215.6M37.4M
Interest Expense26.3M24.9M17.7M943.8M1.3B
Net Interest Income375.7M621.1M817.7M(728.2M)(1.3B)
Other Non-Op Income/Expense1.0B730.4M1.0B(2.6B)(1.8B)
Non-Operating Income (excl Interest)(473.2M)(1.1B)1.7B425.6M
EBT (Pre-Tax Income)(7.6B)(7.9B)(9.6B)(10.4B)(10.4B)
Income Tax Expense
Bottom Line
Net Income(7.6B)(7.9B)(9.6B)(10.4B)(10.4B)
Earnings from Cont. Ops(7.6B)(7.9B)(9.6B)(10.4B)(10.4B)
Earnings from Discont. Ops
Bottom Line Net Income(7.6B)(7.9B)(9.6B)(10.4B)(10.4B)
Per Share
Basic EPS(₩539)(₩566)(₩683)(₩1,316)(₩1,948)
Diluted EPS(₩539)(₩566)(₩683)(₩1,316)(₩1,948)
Revenue Per Share₩391₩380₩243₩509₩490
Shares
Basic Shares Outstanding14.3M14.0M14.0M7.9M5.4M
Diluted Shares Outstanding14.3M14.0M14.0M7.9M5.4M
Profitability Metrics
EBITDA(7.1B)(7.2B)(8.0B)(7.8B)(7.6B)
D&A1.3B1.4B1.6B1.6B1.5B
EBIT(8.3B)(8.7B)(9.6B)(9.5B)(9.1B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026